Genes in MS Patients Riverhead NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Seymore Molinoff
(631) 444-6300
450 Waverly Avenue Suite 1
Patchogue, NY
Kalpana Patel
(516) 924-1000
Longwood Road
Middle Island, NY
Terri A Rauch
631-287-1155
414 County Rd. 39A 
Southampton, NY
Nicholas Miceli
631-289-1151
450 Waverly Ave. 
Patchogue, NY
Robert S MacBarb
631-725-0106
POB 1657 Main St. 
Sag Harbor, NY
David Reavis
(631) 444-6300
450 Waverly Avenue
Patchogue, NY
Joseph Michael Venezia
(516) 821-0505
765 Route 25A
Miller Place, NY
Susan D DeBevoise
(516) 924-1000
Longwood Road
Middle Island, NY
George H Dale
631-286-4584
8 Prairie Ln. 
Brookhaven, NY
Daniel C Gozdziewski
631-968-8511
19 Windjammer Crossing 
Manorville, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Genetic Clues for Skin Cancer Therapies Riverhead NY
Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.
- Gene Variants and Alzheimer's Risk Riverhead NY
- Exercise for Chemotherapy Patients Riverhead NY
- Gene Therapy for Parkinson's Riverhead NY
- High Blood Pressure Genes Riverhead NY
- Side Effect Of Chemotherapy Drugs Riverhead NY
- Depression in Heart Disease Patients Riverhead NY
- Doctor-Patient Talk for Hypertension Riverhead NY
- Hospice: Getting Back Control of Your Life Riverhead NY
- Differences Between Hospice and Palliative Care Riverhead NY